Mills EJ, Wu P, Chong G. Ghement I, Singh S, Akl EA, et al.. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM 2011; 104(2): 109-24.
Kereiakes DJ, Robinson JG, Cannon CP, Lorenzato C, Pordy R, Chaudhari U, et al. Efficacy and safety of the proprotein convertase
subtil-isin/kexin type 9 inhibitor alirocumab among high cardiovascular
risk patients on maximally tolerated statin therapy: The ODYSSEY
COMBO I study. American heart journal 2015; 169(6): 906-15. e13
Teramoto T, Kobayashi M, Tasaki H. Yagyu H, Higashikata T,
Takagi Y,. Efficacy and safety of alirocumab in japanese patients with heterozygous familial hypercholesterolemia or at high car-diovascular risk With hypercholesterolemia not adequately controlled with statins- odyssey japan randomized controlled trial. Circulation Journal: Official Journal of the Japanese Circulation Society 2016; 80(9): 1980-7.